Key result
Flecainide exhibited proarrhythmic effects, increasing reentry duration in 14 of 14 trials at 0.3 mg/L and 2 of 15 trials at 1.0 mg/L in an in vitro canine tricuspid ring model.
Why the study?
Does flecainide alter the duration of nonsustained reentry in a canine atrial tricuspid ring in vitro model?
Does flecainide alter the duration of nonsustained reentry in a canine atrial tricuspid ring in vitro model?
Flecainide exhibits dose-dependent proarrhythmic and antiarrhythmic effects on atrial reentry in vitro, driven by its differential effects on tachycardia cycle length and effective refractory period.
Alerts to potential proarrhythmia with flecainide in atrial tissue; leaves open translation to clinical AF management.
The effect of flecainide, 0.3 mg/L and 1.0 mg/L, on inducible nonsustained reentry was studied, in vitro, in the canine tricuspid ring. Nonsustained reentry was engineered by cutting the ring and reconnecting it with an adjustable electronic delay. Delays were used that produced reentry lasting 1-3 beats (group A), 4-10 beats (group B), and 11-25 beats (group C). Reentry was initiated multiple times at each selected delay. A proarrhythmic effect, defined as a significant increase in the duration of reentry, was observed in all 14 trials at the low dose and in two of 15 trials at the high dose in seven experiments. In four more trials a transient proarrhythmic response was seen initially during exposure to the high dose. In five of seven experiments, reentry became sustained after at least one dose of flecainide. Proarrhythmic responses resulted when flecainide increased the tachycardia cycle length more than the effective refractory period and there was less cycle length oscillation after initiation. Antiarrhythmic responses resulted either from a marked increase in effective refractory period at the site of block or production of fixed block.
No takes yet. Share an insight, caveat, or question.
Frame et al. (1991) studied Nonsustained reentry (n=7). Flecainide was evaluated on Proarrhythmic effect (significant increase in the duration of reentry). Flecainide exhibited proarrhythmic effects, increasing reentry duration in 14 of 14 trials at 0.3 mg/L and 2 of 15 trials at 1.0 mg/L in an in vitro canine tricuspid ring model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: